We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Molina Healthcare (MOH) Q4 Earnings & Revenues Top Estimates
Read MoreHide Full Article
Molina Healthcare, Inc.’s (MOH - Free Report) fourth-quarter 2018 adjusted earnings of $3.88 per share surpassed the Zacks Consensus Estimate of $1.52 by a whopping 155.3%. This upside was driven by higher premium revenues as well as decreasing expenses. The bottom line also reversed the year-ago period’s loss of 34 cents.
For the quarter under review, total revenues came in at $4.6 billion, beating the Zacks Consensus Estimate by 1.8%. However, the top line declined 5.7% year over year, mainly due to lower premium and service revenues.
Quarterly Operational Update
The company’s net income totaled $201 million against its year-earlier period's loss of $262 million.
Total operating expenses declined about 16.8% year over year to $4.3 billion. This improvement was attributable to lower medical care costs and cost of service revenues.
For the fourth quarter, medical care cost was down 11.2% year over year to nearly $3.8 billion.
Molina Healthcare’s interest expenses were down 27.2% year over year to $24 million.
In the quarter under review, the company sold its Pathways behavioral health subsidiary due to which it suffered a net loss of $32 million.
The total membership by Government Program for 2019 stands at 3.8 billion, down 14.2% year over year.
Molina Healthcare, Inc Price, Consensus and EPS Surprise
As of Dec 31, 2018, Molina Healthcare’s cash and cash equivalents saw a reduction of 11.3% to $2.8 billion from the level at year-end 2017.
Total assets fell 15.6% from 2017 end to $7.1 billion.
The company’s shareholder equity improved nearly 23.2% from the figure at year-end 2017 to $1.6 billion.
For the fourth quarter, net cash outflow from operating activities stands at $123 million, narrower than the year-ago period's net cash outflow of $153 million.
Full-Year Highlights
Total revenues for 2019 declined 5% to $18.9 billion. Net income per share stands at $10.61 against the prior-year period's net loss of $9.07.
2019 Guidance
For 2019, the company expects its premium revenues to be $15.8 billion.
Its total revenues are projected at $16.3 billion.
Moreover, Medicare costs are expected to be $13.7 billion. General and administrative expenses are estimated at $1.2 billion.
Net income of the company is anticipated in the band of $600-$630 million. EBITDA is projected in the bracket of $975-$1025 million.
Net income per share is predicted to be $9.25-$9.75.
Medicaid and Medicare membership is forecast to be around 3.2 million whereas Marketplace membership is estimated to be around 250-275 million.
Some other stocks worth considering from the medical sector are as follows:
Constellation Pharmaceuticals, Inc. is set to report fourth-quarter 2018 earnings performance on Feb 14. The stock has an Earnings ESP of +9.72% and a Zacks Rank of 1.
Tenet Healthcare Corporation (THC - Free Report) is slated to announce fourth-quarter earnings results on Feb 25. The company has an Earnings ESP of +5.63% and a Zacks Rank of 3.
Alder BioPharmaceuticals, Inc. has an Earnings ESP of +13.52% and a Zacks Rank #3 (Hold). The company is scheduled to release fourth-quarter earnings numbers on Feb 25.
Zacks' Best Stock-Picking Strategy
It's hard to believe, even for us at Zacks. But from 2000-2018, while the market gained +4.8% per year, our top stock-picking strategy averaged +54.3% per year.
How has that screen done lately? From 2017-2018, it sextupled the market's +15.8% gain with a soaring +98.3% return.
Image: Bigstock
Molina Healthcare (MOH) Q4 Earnings & Revenues Top Estimates
Molina Healthcare, Inc.’s (MOH - Free Report) fourth-quarter 2018 adjusted earnings of $3.88 per share surpassed the Zacks Consensus Estimate of $1.52 by a whopping 155.3%. This upside was driven by higher premium revenues as well as decreasing expenses. The bottom line also reversed the year-ago period’s loss of 34 cents.
For the quarter under review, total revenues came in at $4.6 billion, beating the Zacks Consensus Estimate by 1.8%. However, the top line declined 5.7% year over year, mainly due to lower premium and service revenues.
Quarterly Operational Update
The company’s net income totaled $201 million against its year-earlier period's loss of $262 million.
Total operating expenses declined about 16.8% year over year to $4.3 billion. This improvement was attributable to lower medical care costs and cost of service revenues.
For the fourth quarter, medical care cost was down 11.2% year over year to nearly $3.8 billion.
Molina Healthcare’s interest expenses were down 27.2% year over year to $24 million.
In the quarter under review, the company sold its Pathways behavioral health subsidiary due to which it suffered a net loss of $32 million.
The total membership by Government Program for 2019 stands at 3.8 billion, down 14.2% year over year.
Molina Healthcare, Inc Price, Consensus and EPS Surprise
Molina Healthcare, Inc Price, Consensus and EPS Surprise | Molina Healthcare, Inc Quote
Financial Update
As of Dec 31, 2018, Molina Healthcare’s cash and cash equivalents saw a reduction of 11.3% to $2.8 billion from the level at year-end 2017.
Total assets fell 15.6% from 2017 end to $7.1 billion.
The company’s shareholder equity improved nearly 23.2% from the figure at year-end 2017 to $1.6 billion.
For the fourth quarter, net cash outflow from operating activities stands at $123 million, narrower than the year-ago period's net cash outflow of $153 million.
Full-Year Highlights
Total revenues for 2019 declined 5% to $18.9 billion. Net income per share stands at $10.61 against the prior-year period's net loss of $9.07.
2019 Guidance
For 2019, the company expects its premium revenues to be $15.8 billion.
Its total revenues are projected at $16.3 billion.
Moreover, Medicare costs are expected to be $13.7 billion. General and administrative expenses are estimated at $1.2 billion.
Net income of the company is anticipated in the band of $600-$630 million. EBITDA is projected in the bracket of $975-$1025 million.
Net income per share is predicted to be $9.25-$9.75.
Medicaid and Medicare membership is forecast to be around 3.2 million whereas Marketplace membership is estimated to be around 250-275 million.
Zacks Rank
Molina Healthcare sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Upcoming Releases From Medical Sector
Some other stocks worth considering from the medical sector are as follows:
Constellation Pharmaceuticals, Inc. is set to report fourth-quarter 2018 earnings performance on Feb 14. The stock has an Earnings ESP of +9.72% and a Zacks Rank of 1.
Tenet Healthcare Corporation (THC - Free Report) is slated to announce fourth-quarter earnings results on Feb 25. The company has an Earnings ESP of +5.63% and a Zacks Rank of 3.
Alder BioPharmaceuticals, Inc. has an Earnings ESP of +13.52% and a Zacks Rank #3 (Hold). The company is scheduled to release fourth-quarter earnings numbers on Feb 25.
Zacks' Best Stock-Picking Strategy
It's hard to believe, even for us at Zacks. But from 2000-2018, while the market gained +4.8% per year, our top stock-picking strategy averaged +54.3% per year.
How has that screen done lately? From 2017-2018, it sextupled the market's +15.8% gain with a soaring +98.3% return.
Free – See the Stocks It Turned Up for Today >>